Showing 1 - 10 of 14
Persistent link: https://www.econbiz.de/10011005457
Persistent link: https://www.econbiz.de/10010545879
This paper critically reviews theoretical and empirical propositions regarding visual analogue scale (VAS) valuations of health states and their use in cost-utility analysis (CUA). A widely repeated assertion in the economic evaluation literature is the inferiority, on theoretical grounds, of...
Persistent link: https://www.econbiz.de/10005440519
The decisions made by the National Institute for Clinical Excellence (NICE) give rise to two questions: how is cost-effectiveness evidence used to make judgements about the 'value for money' of health technologies? And how are factors other than cost-effectiveness taken into account? The aim of...
Persistent link: https://www.econbiz.de/10005440585
Persistent link: https://www.econbiz.de/10005442623
Persistent link: https://www.econbiz.de/10005442759
ABSTRACT This paper describes the development of a methodology for the case‐mix adjustment of patient‐reported outcome measures (PROMs) data permitting the comparison of outcomes between providers on a like‐for‐like basis. Statistical models that take account of provider‐specific...
Persistent link: https://www.econbiz.de/10011160893
Patterns of self-reported morbidity and general practitioner (GP) utilization exhibit complex age, sex and time heterogeneity. Underlying patterns are often obscured by data which are overly 'rough' because of noise associated with adjacent year fluctuations. In this paper we describe methods to...
Persistent link: https://www.econbiz.de/10005792735
HASH(0x1009b7638)
Persistent link: https://www.econbiz.de/10008455467
Persistent link: https://www.econbiz.de/10010638661